ENDOTOXIN-MEDIATED CHANGES IN PLASMA ENDOTHELIN CONCENTRATIONS, RENALENDOTHELIN RECEPTOR AND RENAL-FUNCTION

Citation
P. Nambi et al., ENDOTOXIN-MEDIATED CHANGES IN PLASMA ENDOTHELIN CONCENTRATIONS, RENALENDOTHELIN RECEPTOR AND RENAL-FUNCTION, Pharmacology, 48(3), 1994, pp. 147-156
Citations number
41
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
00317012
Volume
48
Issue
3
Year of publication
1994
Pages
147 - 156
Database
ISI
SICI code
0031-7012(1994)48:3<147:ECIPEC>2.0.ZU;2-7
Abstract
The purpose of these studies was to examine the changes in renal endot helin (ET) receptor, renal function and plasma ET (ET-1) concentration in male Sprague-Dawley rats injected with nonlethal doses of Escheric hia coli endotoxin (LPS). Prior to the injection of LPS, kidney ET rec eptor density was 59 +/- 5 fmol/mg protein (n = 20). At 24 h after the injection of 1 or 3 mg/kg LPS, [I-125]ET-1 binding to kidney membrane s was increased by 70% in both LPS groups (p < 0.001). Scatchard analy sis of the saturation binding experiments confirmed that the increase in ([)125)I]ET-1 binding was due to an increase in receptor density wi th no change in affinity (202 pmol/l at baseline and 168 pmol/1 and 24 6 pmol/l at 24 h after the injection of 1 and 3 mg/kg LPS, respectivel y). At 7 days after the injection of LPS, kidney ET-1 receptor density was still increased by 30 +/- 5% and 58 +/- 16%, respectively (p < 0. 05, compared to the baseline value). Baseline values for Na+ and K+ ex cretion were approximately 115 mu Eq/h and 214 +/- mu Eq/h respectivel y, and were decreased with LPS. Maximal decreases in Na+ and K+ excret ion occurred at 48 h (-85%) and 30 h (-82%), respectively, following t he injection of 3 mg/kg LPS and returned to baseline levels in 7 days. Following the injection of 3 mg/kg LPS, plasma immunoreactive ET-1, a s measured by radioimmunoassay, increased in a time-dependent manner: the maximal increase of 60% occurred within 1 h after the injection of LPS (p < 0.05), and thereafter returned to baseline levels. Kidney ti ssue levels of ET-1 increased from baseline values of 2.6 fmol/mg prot ein to a peak of 4.6 fmol/mg protein 1 h after the injection of LPS. T issue ET-1 levels were still significantly elevated at 6 h but not 24 h after LPS injection. These studies suggest that ET-1, either by incr eases in plasma concentration and/or altered receptor density, may be involved in the LPS-induced impairment of renal function.